Affinity BioReagents - Ownership and Business Overview

Life ScienceCompany

Affinity BioReagents Ownership

Who owns Affinity BioReagents?

Affinity BioReagents is owned by Thermo Fisher Scientific. It was acquired on July 17, 2008.

Affinity BioReagents Business Overview

Where is Affinity BioReagents headquartered?

Affinity BioReagents is headquartered in Golden, Colorado.

What sector is Affinity BioReagents in?

Affinity BioReagents is a life science company.

When was Affinity BioReagents founded?

Affinity BioReagents was founded in 1989.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

Affinity BioReagents, Inc.

4620 Technology Drive, Suite 600,
Golden, Colorado 80403
United States,
(303) 278-4535
www.bioreagents.com

Affinity BioReagents, Inc., is a provider of antibodies, peptides, proteins and other reagents for life science research, based in Golden, Colorado. Affinity BioReagents has an offering of more than 35,000 reagents - primarily monoclonal and polyclonal antibodies - which are used in numerous fields of medical and academic research, as well as drug discovery. The company also provides recombinant proteins and custom antibody-production services.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.